Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add filters








Year range
1.
Chinese Journal of Experimental Traditional Medical Formulae ; (24): 37-44, 2024.
Article in Chinese | WPRIM | ID: wpr-1016460

ABSTRACT

ObjectiveTo investigate the antiviral effect of Menispermi Rhizoma total alkaloids and its relationship with the type Ⅰ interferon (IFN-Ⅰ) signaling pathway. MethodThe effects of Menispermi Rhizoma total alkaloids on the intracellular replication of influenza A virus (H1N1), vesicular stomatitis virus (VSV), and cerebral myocarditis virus (EMCV) were detected by fluorescent inverted microscope, flow cytometry, Real-time fluorescence quantitative polymerase chain reaction (Real-time PCR), and Western blot. A mouse model infected with H1N1 was constructed, and the mice were divided into a control group, H1N1 model group, Menispermi Rhizoma total alkaloids groups (10, 20, 30 mg·kg-1), and oseltamivir group (40 mg·kg-1), so as to study the effects on the weight and survival rate of infected mice. Real-time PCR was used to detect the activation effect of Menispermi Rhizoma total alkaloids on the IFN-Ⅰ pathway in cells, and the relationship between the antiviral effect of Menispermi Rhizoma total alkaloids in IFNAR1 knockout A549 cells (IFNAR1-/--A549) and IFN-Ⅰ pathway was detected. ResultCompared with the control group, the virus proliferated significantly in the model group (P<0.01). Compared with the model group, Menispermi Rhizoma total alkaloids could significantly inhibit the replication of H1N1, VSV, and EMCV in vitro (P<0.01), inhibit the weight loss of the mice infected with the H1N1 in vivo, and improve the survival rate of mice (P<0.05). In addition, Menispermi Rhizoma total alkaloids activated the IFN-I pathway and relied on this pathway to exert the function of antiviral infection. ConclusionMenispermi Rhizoma total alkaloids exert antiviral effects in vivo and in vitro by activating the IFN-Ⅰ pathway.

2.
Acta Pharmaceutica Sinica B ; (6): 2310-2333, 2023.
Article in English | WPRIM | ID: wpr-982883

ABSTRACT

Periodontitis is an inflammatory disease caused by bacterial infection directly, and the dysregulation of host immune-inflammatory response finally destroys periodontal tissues. Current treatment strategies for periodontitis mainly involve mechanical scaling/root planing (SRP), surgical procedures, and systemic or localized delivery of antimicrobial agents. However, SRP or surgical treatment alone has unsatisfactory long-term effects and is easy to relapse. In addition, the existing drugs for local periodontal therapy do not stay in the periodontal pocket long enough and have difficulties in maintaining a steady, effective concentration to obtain a therapeutic effect, and continuous administration always causes drug resistance. Many recent studies have shown that adding bio-functional materials and drug delivery systems upregulates the therapeutic effectiveness of periodontitis. This review focuses on the role of biomaterials in periodontitis treatment and presents an overview of antibacterial therapy, host modulatory therapy, periodontal regeneration, and multifunctional regulation of periodontitis therapy. Biomaterials provide advanced approaches for periodontal therapy, and it is foreseeable that further understanding and applications of biomaterials will promote the development of periodontal therapy.

3.
International Journal of Laboratory Medicine ; (12): 1755-1756,1759, 2016.
Article in Chinese | WPRIM | ID: wpr-604328

ABSTRACT

Objective To investigate the resistance of clinically isolated bacteria to commonly used antibacterial drugs in the First Affiliated Hospital of Chongqing Medical University .Methods The bacterial susceptibility testing in clinically isolated bacte‐ria collected during January to December 2014 was carried out .The detection results were judged according to the standards by CLSI in 2014 .Results Among 7 740 clinical isolated strains of bacteria collected during this period ,Gram negative bacteria and Gram positive bacteria accounted for 70 .6% and 29 .4% respectively .Methicillin resistant(MR) strains in S .aureus and coagulase negative Staphylococcus accounted for 30 .2% and 77 .2% respectively .The resistance rates of MR strains to main antimicrobial a‐gents were much higher than those of methicillin sensitive(MS) strains .No staphylococcal strain was resistant to vancomycin or lin‐ezolid .The resistance rates of E .faecalis strains to main antibacterial agents was much lower than those of E .faecium .Some strains (2 .3% ) of E .faecium were found resistant to vancomycin ,while some strains(0 .9% ) of E .faecalis were found resistant to linezol‐id .The ESBLs producing strains were 59 .5% in Escherichia coli and 31 .8% in Klebsiella pneumoniae .Strains of Enterobacteriaceae were highly susceptible to imipenem and meropenem ,the overall resistance rates being less than 2 .0% .Resistance rates of P .aerug‐inosa to imipenem and meropenem were 24 .5% and 17 .9% ,respectively .The resistance rates of A .baumanii to the two carbapene‐ms were 71 .9% and 75 .0% ,respectively .The multi‐drug resistant K .pneumoniae and A .baumanii were increased markedly .Con‐clusion Bacterial drug resistance is serious ,especially the multi‐drug resistant bacteria constitute a serious threat to clinic .There‐fore it is urgent to strengthen the infection control measures .

4.
International Journal of Laboratory Medicine ; (12): 2644-2645, 2014.
Article in Chinese | WPRIM | ID: wpr-458935

ABSTRACT

Objective To investigate the antimicrobial resistance of Enterococcus f aecalis and Enterococcus f aecium isolated from the First Affiliated Hospital of Chongqing Medical University between 2009 and 2012 .Methods Antimicrobial susceptibility testing was carried out according to the unified protocol .The dates were analyzed by WHONET 5 .6 software according to clinical and laboratory standards institute(CLSI) of 2012 .Results A total of 783 non-repetitive Enterococcus f aecalis and 664 non-repeti-tive Enterococcus f aecium isolates were collected .The strains were still highly susceptible to linezolid and vancomycin .The resist-ance rates were all less than 2 .0% .The resistance rates of vancomycin to Enterococcus f aecalis and Enterococcus f aecium were 0 .1% and 1 .4% ,respectively .The percentage of Enterococcus f aecalis resistant to ampicillin ,penicilin and nitrofurantoin were 5 .7% ,2 .6% and 2 .2% ,respectively .About 32 .9% of Enterococcus f aecalis isolates were resistant to gentamicin .The resistance rates of ampicillin and penicillin to Enterococcus f aecium were more than 90 .0% .Conclusion Enterococcus f aecalis is main En-terococcus in the First Affiliated Hospital of Chongqing Medical University .There is an obvious difference between the antibiotic re-sistance of the Enterococcus f aecalis and Enterococcus f aecium .So ,monitoring drug resistance of the Enterococcus shows great sig-nificance to the clinical treatment .

SELECTION OF CITATIONS
SEARCH DETAIL